317 related articles for article (PubMed ID: 24028612)
41. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
42. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
Abdel-Mottaleb MM; Neumann D; Lamprecht A
Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002
[TBL] [Abstract][Full Text] [Related]
43. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
Cirri M; Bragagni M; Mennini N; Mura P
Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
[TBL] [Abstract][Full Text] [Related]
44. Preparation and characterization of triclosan nanoparticles intended to be used for the treatment of acne.
Domínguez-Delgado CL; Rodríguez-Cruz IM; Escobar-Chávez JJ; Calderón-Lojero IO; Quintanar-Guerrero D; Ganem A
Eur J Pharm Biopharm; 2011 Sep; 79(1):102-7. PubMed ID: 21295142
[TBL] [Abstract][Full Text] [Related]
45. Enhanced skin permeation using polyarginine modified nanostructured lipid carriers.
Shah PP; Desai PR; Channer D; Singh M
J Control Release; 2012 Aug; 161(3):735-45. PubMed ID: 22617521
[TBL] [Abstract][Full Text] [Related]
46. Super-short solid silicon microneedles for transdermal drug delivery applications.
Li WZ; Huo MR; Zhou JP; Zhou YQ; Hao BH; Liu T; Zhang Y
Int J Pharm; 2010 Apr; 389(1-2):122-9. PubMed ID: 20096759
[TBL] [Abstract][Full Text] [Related]
47. In vitro and in vivo evaluations of ketoprofen extended release pellets prepared using powder layering technique in a rotary centrifugal granulator.
Pai R; Kohli K; Jain G; Srivastava B
Arch Pharm Res; 2011 Jul; 34(7):1135-42. PubMed ID: 21811920
[TBL] [Abstract][Full Text] [Related]
48. Poly (vinyl alcohol) microneedles: Fabrication, characterization, and application for transdermal drug delivery of doxorubicin.
Nguyen HX; Bozorg BD; Kim Y; Wieber A; Birk G; Lubda D; Banga AK
Eur J Pharm Biopharm; 2018 Aug; 129():88-103. PubMed ID: 29800617
[TBL] [Abstract][Full Text] [Related]
49. Nanodesign of olein vesicles for the topical delivery of the antioxidant resveratrol.
Pando D; Caddeo C; Manconi M; Fadda AM; Pazos C
J Pharm Pharmacol; 2013 Aug; 65(8):1158-67. PubMed ID: 23837583
[TBL] [Abstract][Full Text] [Related]
50. Development of a novel ketoprofen transdermal patch: effect of almond oil as penetration enhancers on in-vitro and ex-vivo penetration of ketoprofen through rabbit skin.
Hussain A; Khan GM; Shah SU; Shah KU; Rahim N; Wahab A; Rehman AU
Pak J Pharm Sci; 2012 Jan; 25(1):227-32. PubMed ID: 22186334
[TBL] [Abstract][Full Text] [Related]
51. Nanocarriers for dermal drug delivery: influence of preparation method, carrier type and rheological properties.
Schwarz JC; Weixelbaum A; Pagitsch E; Löw M; Resch GP; Valenta C
Int J Pharm; 2012 Nov; 437(1-2):83-8. PubMed ID: 22903049
[TBL] [Abstract][Full Text] [Related]
52. Controlled delivery of ropinirole hydrochloride through skin using modulated iontophoresis and microneedles.
Singh ND; Banga AK
J Drug Target; 2013 May; 21(4):354-66. PubMed ID: 23311703
[TBL] [Abstract][Full Text] [Related]
53. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility.
Wu Y; Qiu Y; Zhang S; Qin G; Gao Y
Biomed Microdevices; 2008 Oct; 10(5):601-10. PubMed ID: 18324474
[TBL] [Abstract][Full Text] [Related]
54. Development of Poly (Methyl vinyl ether-alt-maleic acid) Microneedles for Transdermal Delivery of Atorvastatin Calcium.
Castañeda PS; Domínguez Delgado CL; Cruz IMR; Contreras LMM; Trinidad EMM; Cervantes ML; Escobar-Chávez JJ
Curr Pharm Biotechnol; 2020; 21(9):852-861. PubMed ID: 32065098
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of solid lipid microparticles produced by spray congealing for topical application of econazole nitrate.
Passerini N; Gavini E; Albertini B; Rassu G; Di Sabatino M; Sanna V; Giunchedi P; Rodriguez L
J Pharm Pharmacol; 2009 May; 61(5):559-67. PubMed ID: 19405993
[TBL] [Abstract][Full Text] [Related]
56. Permeability enhancement for transdermal delivery of large molecule using low-frequency sonophoresis combined with microneedles.
Han T; Das DB
J Pharm Sci; 2013 Oct; 102(10):3614-22. PubMed ID: 23873449
[TBL] [Abstract][Full Text] [Related]
57. Topical drug delivery by a polymeric nanosphere gel: Formulation optimization and in vitro and in vivo skin distribution studies.
Batheja P; Sheihet L; Kohn J; Singer AJ; Michniak-Kohn B
J Control Release; 2011 Jan; 149(2):159-67. PubMed ID: 20950659
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery.
Alsarra IA
J Microencapsul; 2009 May; 26(3):272-8. PubMed ID: 18720197
[TBL] [Abstract][Full Text] [Related]
59. Liposome surface charge influence on skin penetration behaviour.
Gillet A; Compère P; Lecomte F; Hubert P; Ducat E; Evrard B; Piel G
Int J Pharm; 2011 Jun; 411(1-2):223-31. PubMed ID: 21458550
[TBL] [Abstract][Full Text] [Related]
60. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
